4.3 Article

Endoscopic management of refractory gastroesophageal reflux disease

Journal

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
Volume 53, Issue 4, Pages 390-397

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/00365521.2018.1445775

Keywords

Refractory; GERD; endoscopic treatment

Ask authors/readers for more resources

Objective: Despite the therapeutic and surgical interventions for the management of gastroesophageal reflux disease (GERD), yet the high cost and the post-operative complications had led to a significant socioeconomic burden. The aim was to evaluate the safety and efficacy of endoscopic band ligation (EBL) in the management of refractory GERD.Methods: A total of 150 patients with refractory GERD were assigned to an EBL group (banding was done at four quadrants just at the gastroesophageal junction (GEJ) (n=75) or to a control group (optimized dose of PPI, n=75). Follow-up for both groups by upper GI endoscopy to evaluate the site of the Z line from the incisors, the width of the GEJ and the coaptation of GEJ around the endoscope on retroflection. PH monitoring was performed every 3 months with GERD- QoL assessment monthly for 1 year.Results: In EBL group; 58 patients (77.3%) needed 1 session, 17 patients (22.7%) needed 2 sessions. 4 rubber bands were utilized in 44 patients (58.7%), 3 rubber bands in 31 patients (41.3%). Follow-up for 1 year revealed a highly significant improvement of the GERD- QoL score, the site of Z line with significant reduction of reflux episodes and symptom index when compared to the medical treatment group. In EBL group; there were no major adverse events including bleeding, post band ulcers, stenosis at one year follow up.Conclusion: The current study provides a novel endoscopic intervention to treat refractory GERD, which is safe, cost-effective, with no major adverse effects at one year follow up.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Ascitic Calprotectin as an early predictor of hepatocellular carcinoma in patients with cirrhotic ascites

Amr Shaaban Hanafy, Mohamed Sorour Mohamed, Ahmed A. Alnagar

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)

Article Gastroenterology & Hepatology

Impact of laparoscopic cholecystectomy on the complexity of endoscopic retrograde cholangiopancreatography

Waseem M. Seleem, Amr S. Hanafy, Sherief Abd-Elsalam, Rehab Badawi

Summary: Complicated cholecystectomy has a significant impact on the complexity and safety of ERCP procedure, leading to prolonged procedure duration, increased cannulation attempts, difficulty in pancreatic duct cannulation, difficult or failed stone extraction, and higher occurrence of post-ERCP pancreatitis.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2022)

Review Gastroenterology & Hepatology

Challenges in COVID-19 drug treatment in patients with advanced liver diseases: A hepatology perspective

Amr Shaaban Hanafy, Sherief Abd-Elsalam

WORLD JOURNAL OF GASTROENTEROLOGY (2020)

Editorial Material Gastroenterology & Hepatology

Prediction and Prevention of Post-hepatectomy Liver Failure: Where Do We Stand?

Amr Shaaban Hanafy

JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

The Additive Effect of Platelet-Rich Plasma in the Treatment of Actively Bleeding Peptic Ulcer

Waseem M. Seleem, Amr Shaaban Hanafy

Summary: The study found that PRP has additional benefits in the treatment of peptic ulcer bleeding, reducing the occurrence of rebleeding and improving patients' recovery rate. No significant complications were reported in the PRP group.

CLINICAL ENDOSCOPY (2021)

Article Medicine, Research & Experimental

Potential impact of combined influenza and pneumococcal vaccines on the severity of respiratory illness in COVID-19 infection among type 2 diabetic patients

Amr Shaaban Hanafy, Waseem M. Seleem, Hany A. Elkattawy

Summary: This study retrospectively assessed the impact of yearly administration of recombinant influenza and single administration of pneumococcal conjugate vaccines on the occurrence of serious respiratory infection including COVID-19 in patients with type 2 diabetes mellitus. The results showed that the vaccines led to improvements in respiratory symptoms, inflammatory parameters, and a decrease in the severity of COVID-19 in diabetic patients.

CLINICAL AND EXPERIMENTAL MEDICINE (2023)

Correction Oncology

Ascitic Calprotectin as an early predictor of hepatocellular carcinoma in patients with cirrhotic ascites (vol 146, pg 3207, 2020)

Amr Shaaban Hanafy, Mohamed Sorour Mohamed, Ahmed A. Alnagar

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2022)

Article Gastroenterology & Hepatology

ABC: a novel algorithm to stratify decompensation risk in patients with compensated advanced chronic liver disease (CHESS2108): an international, multicenter cohort study

Chuan Liu, Jia Li, Yu Jun Wong, Qing Xie, Masashi Hirooka, Hirayuki Enomoto, Tae Hyung Kim, Amr Shaaban Hanafy, Ruiling He, Yohei Koizumi, Yoichi Hiasa, Takashi Nishimura, Hiroko Iijima, Young Kul Jung, Hyung Joon Yim, Jianzhong Ma, Qing-Lei Zeng, Shiv Kumar Sarin, Xiaolong Qi

Summary: Background liver-related death is often preceded by clinical decompensation in compensated advanced chronic liver disease (cACLD), making risk stratification of decompensation extremely important. A new CHESS criteria and ABC model were developed to stratify decompensation risk, showing promising results in predicting hepatic decompensation in cACLD patients. HVPG evaluation can be waived in low and high-risk cACLD patients managed by Baveno VI criteria and non-selective beta-blockers intervention, with medium-risk patients requiring further evaluation.

HEPATOLOGY INTERNATIONAL (2022)

Article Gastroenterology & Hepatology

A Novel SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102): An International Multicenter Cohort Study

Liu Chuan, Cao Zhujun, Yan Huadong, Wong Yu Jun, Xie Qing, Masashi Hirooka, Hirayuki Enomoto, Tae Hyung Kim, Amr Shaaban Hanafy, Liu Yanna, Huang Yifei, Li Xiaoguo, Kang Ning, Yohei Koizumi, Yoichi Hiasa, Takashi Nishimura, Hiroko Iijima, Young Kul Jung, Hyung Joon Yim, Guo Ying, Zhang Linpeng, Ma Jianzhong, Manoj Kumar, Ankur Jindal, Kok Ban Teh, Shiv Kumar Sarin, Qi Xiaolong

Summary: This study developed a new score (SAVE score) that accurately predicts the risk of hepatic decompensation in cACLD patients and also accurately predicts clinically significant portal hypertension.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2022)

Article Hematology

Clinical utility of haematological inflammatory biomarkers in predicting 30-day mortality in hospitalised adult patients with COVID-19

Ahmed Embaby, Mohamed Gaber Hamed, Huda Ebian, Lobna A. El-Korashi, Mohammad Walaa, Eman M. Abd el-Sattar, Amr Shaaban Hanafy, Shimaa Abdelmoneem

Summary: COVID-19 is a multisystem disease and this study found that PLR, PWR, and RDW levels are significantly associated with mortality in COVID-19 patients. RDW, PLT count, and PWR levels serve as independent prognostic predictors for mortality in COVID-19 patients.

BRITISH JOURNAL OF HAEMATOLOGY (2023)

Article Medicine, Research & Experimental

Impact of gut Microbiome alteration in Ulcerative Colitis patients on disease severity and outcome

Osama Mohammed Basha, Raghda A. Hafez, Sara Mohamed Salem, Reham H. Anis, Amr Shaaban Hanafy

Summary: This study assessed the changes in gut microbiome in ulcerative colitis (UC) patients and found that the levels of different bacteria were inversely proportional to disease severity. After treatment, levels of bacteria associated with disease remission increased, while levels of bacteria associated with disease exacerbation decreased. Lower baseline levels of certain bacteria increased the risk of relapse, while lower levels of other bacteria protected against relapse.

CLINICAL AND EXPERIMENTAL MEDICINE (2023)

Meeting Abstract Gastroenterology & Hepatology

ABC: a novel algorithm to stratify decompensation risk in patients with cACLD (CHESS2102): an international, multicenter cohort study

Chuan Liu, Jia Li, Yu Jun Wong, Qing Xie, Masashi Hirooka, Hirayuki Enomoto, Tae Hyung Kim, Amr Hanafy, Zhujun Cao, Lili Zhao, Yanna Liu, Yifei Huang, Xiaoguo Li, Ning Kang, Yohei Koizumi, Yoichi Hiasa, Takashi Nishimura, Hiroko Iijima, Young Kul Jung, Hyung Joon Yim, Xin Li, Qing-Lei Zeng, Xiaolong Qi

JOURNAL OF HEPATOLOGY (2022)

Review Gastroenterology & Hepatology

Differentiation of malignant from non-malignant portal vein thrombosis in liver cirrhosis: the challenging dilemma

Amr Shaaban Hanafy, Essam Elsayed Tharwat

Summary: Portal vein thrombosis is not uncommon in patients with liver cirrhosis, with the malignant variant being the most frequent. Efforts should be focused on excluding benign PVT, which may dramatically change the management of patients.

EGYPTIAN LIVER JOURNAL (2021)

Article Gastroenterology & Hepatology

Predictors of residual hepatic reserve and hepatic decompensation in cirrhotic patients after ablated hepatocellular carcinoma treated by DDAs or systemic therapy

Amr Shaaban Hanafy, Mohamed Sorour Mohamed, Mohamed Abu Taleb, H. M. Mohammed, Tarek M. H. Ibrahim, Sameh Saber, Hesham A. Atia

Summary: Non-invasive parameters of residual hepatic reserve are promising tools to guide therapy and avoid further complications in patients with liver cirrhosis and ablated HCC.

EGYPTIAN LIVER JOURNAL (2021)

Article Gastroenterology & Hepatology

Novel markers of endothelial dysfunction in hepatitis C virus-related cirrhosis: More than a mere prediction of esophageal varices

Amr Shaaban Hanafy, Mohamed Abdel Khalik Basha, Fady Maher Wadea

WORLD JOURNAL OF HEPATOLOGY (2020)

No Data Available